Wednesday, 18 Sep 2019

TNF inhibitor

Date Typesort ascending Title Save
17 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg
06 Sep 2015 Social 2013 global sales: ETN $11.1 bill, INFL 9.9 bill, ADA 8.9 bill. RA sales increase from $56B in 2013 to $80B in 2020
08 Aug 2016 Slide of the day Tuberculosis Risk Reduction Measures
29 Feb 2016 Slide of the day How to manage TNFi during surgery
29 Aug 2016 Slide of the day Non-Tuberculous Mycobacterial Infection are Common with TNF Inhibitors
24 Jul 2019 Slide of the day anti-TNF Biosimilars in USA
15 May 2017 Slide of the day New TNF Inhibitor Biosimilars
31 Oct 2016 Slide of the day 3 New TNF Inhibitor Biosimilars Approved in 2016
02 May 2016 Blog Why Not Just Kick the TNFi Habit?
16 Nov 2015 Blog The Born Again Rheumatoid
02 Aug 2017 News No Increase in Malformations with Etanercept Use During Pregnancy
02 Nov 2017 News CALM Study: Tight Control with Anti-TNF Wins in Crohn's Disease
02 Mar 2016 News TNF Inhibition and Heart Failure
01 Aug 2019 News TNF Inhibitor and Biologic Induced Psoriasis
27 May 2015 News Nonadherence to Self-Injected Biologics is High
12 Jun 2018 News TNF Inhibitors Don't Increase Cancer Risk in Children
12 Dec 2016 News Random Drug Levels and Anti-Drug Antibodies Predict Rheumatoid Outcomes
28 Apr 2016 News Biosimilar Switching Shows Favorable Interchangeability
13 Jul 2017 News Withdrawal of TNF Inibitors Fails in Most RA Patients
30 Jun 2015 News Utility of Drug Levels and Anti-Drug Antibodies When Starting TNF inhibitors